Unified Women’s Healthcare sets $235 million term loan at 99.5 OID

By Sara Rosenberg

New York, June 29 – Unified Women’s Healthcare LP firmed the original issue discount on its fungible $235 million incremental first-lien term loan due Dec. 18, 2027 at 99.5, the tight end of the 99 to 99.5 talk, according to a market source.

Pricing on the incremental term loan is Libor plus 425 basis points with a 0.75% Libor floor.

Barclays, Credit Suisse Securities (USA) LLC, BofA Securities Inc., RBC Capital Markets, Deutsche Bank Securities Inc. and Antares Capital are the joint bookrunners on the deal. Barclays is the administrative agent.

Proceeds will be used to fund the acquisition of CCRM, a provider of fertility science, research and treatment, and to pay fees and expenses.

Along with this transaction, the company requested certain amendments from existing lenders to allow for the creation of a co-borrower structure with the initial borrower being Unified Women’s Healthcare LP and CCRM Management Co. LLC being added as a co-borrower following the CCRM acquisition and merger and the direct parent of CCRM being added as a guarantor with all of the obligations of Holdings.

Unified Women’s Healthcare is a Boca Raton, Fla.-based practice management platform in women’s health care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.